{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Samuel Berman"}, {"accession": "MS:1000589", "name": "contact email", "value": "bermans@mskcc.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Memorial Sloan Kettering Cancer Center"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Michel Sadelain"}, {"accession": "MS:1000589", "name": "contact email", "value": "m-sadelain@ski.mskcc.org"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Center for Cell Engineering, Memorial Sloan Kettering Cancer Center"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_09AML.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_KASUMI.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_MOLM13.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_MONOMAC.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_TF.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/p492FP_S1_20141212_THPI.raw"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_09AML (F036481).mzid_20141212_09AML_(F036481).MGF"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_KASUMI (F036482).mzid_20141212_KASUMI_(F036482).MGF"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_MOLM13 (F036483).mzid_20141212_MOLM13_(F036483).MGF"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_MONOMAC (F036484).mzid_20141212_MONOMAC_(F036484).MGF"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_TF (F036486).mzid_20141212_TF_(F036486).MGF"}, {"accession": "PRIDE:0000409", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_THPI (F036489).mzid_20141212_THPI_(F036489).MGF"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_09AML (F036481).mzid"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_KASUMI (F036482).mzid"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_MOLM13 (F036483).mzid"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_MONOMAC (F036484).mzid"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_TF (F036486).mzid"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552/20141212_THPI (F036489).mzid"}], "description": "Chimeric antigen receptor (CAR) therapy targeting CD19 yielded remarkable outcomes in patients with acute lymphoblastic leukemia. To identify potential CAR targets in acute myeloid leukemia (AML), we probed the AML surfaceome for over-expressed molecules with potentially tolerable systemic expression. We integrated large transcriptomics and proteomics data sets from malignant and normal tissues, and developed an algorithm to identify potential targets expressed in leukemia stem cells, but not in normal CD34+CD38\u2013 hematopoietic cells, T cells or vital tissues. As these investigations did not uncover candidate targets with a profile as favorable as CD19, we developed a generalizable combinatorial targeting strategy fulfilling stringent efficacy and safety criteria. Our findings indicate that several target pairings hold great promise for CAR therapy of AML.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/10/PXD007552"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD007552"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD007552"}], "instruments": [{"accession": "MS:1001911", "name": "Q Exactive"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Human AML cell lines LC-MSMS, 09AML, KASUMI, MOLM13, MONOMAC, TF, THPI"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biological"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "29017060"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Perna F, Berman SH, Soni RK, Mansilla-Soto J, Eyquem J, Hamieh M, Hendrickson RC, Brennan CW, Sadelain M. Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML. Cancer Cell. 2017 32(4):506-519.e5"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "An Informatic Approach to Chimeric Antigen Receptor Discovery Integrates Proteomics and Transcriptomics to Identify Novel Combinatorial Pairs"}